# Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC

> **NCT06188715** · PHASE3 · COMPLETED · sponsor: **Jennifer Keiser** · enrollment: 224 (actual)

## Conditions studied

- Trichuriasis
- Ascariasis
- Hookworm Infections

## Interventions

- **DRUG:** Moxidectin 2 mg Oral Tablet
- **DRUG:** Albendazole 400 mg Oral Tablet
- **DRUG:** Placebo Moxidectin
- **DRUG:** Placebo Albendazole

## Key facts

- **NCT ID:** NCT06188715
- **Lead sponsor:** Jennifer Keiser
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-14
- **Primary completion:** 2024-08-05
- **Final completion:** 2024-08-05
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2025-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06188715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06188715, "Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06188715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*